Related Experiment Video
Updated: May 9, 2026

Induction of Periodontitis via a Combination of Ligature and Lipopolysaccharide Injection in a Rat Model
Published on: February 17, 2023
Non-drug induced gingival enlargement.
Michelle L Moffitt1, Robert E Cohen
1Department of Periodontics and Endodontics, School ofDental Medicine, University at Buffalo, The State University of New York, NY, USA.
Gingival enlargement, a rise in gum tissue size, stems from various factors including local, systemic, and disease-related causes. Treatment involves surgical or non-surgical methods to manage excess tissue and address underlying causes.
Area of Science:
- Dentistry
- Periodontology
Background:
- Gingival enlargement involves an increase in gingival tissue size.
- Etiology is often multifactorial, including local, systemic, disease, and idiopathic factors.
- Tissue characteristics range from soft/spongy to dense, with darker pigmentation than drug-induced cases.
Purpose of the Study:
- To summarize the etiology, characteristics, and treatment of gingival enlargement.
- To provide a comprehensive overview for clinicians and researchers.
Main Methods:
- Literature review of studies on gingival enlargement.
- Analysis of etiological factors, clinical presentations, and therapeutic approaches.
Main Results:
- Gingival enlargement has diverse causes, including local irritants and systemic conditions.
- Clinical presentation varies in tissue consistency and color.
- Treatment strategies are tailored to the underlying cause and severity.
Conclusions:
- Effective management of gingival enlargement requires accurate diagnosis of its multifactorial etiology.
- Treatment modalities should be individualized, combining surgical, non-surgical, and etiological factor management.
- Further research into specific etiological pathways can refine treatment protocols.
Related Concept Videos
Goiter
The Oral Microbiota
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
GPCRs Regulate Adenylyl Cylase Activity
Two...
Drug Toxicity: Dose-Dependent Reactions

